...
首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Susceptibility Loci Associations with Prostate Cancer Risk in Northern Chinese Men
【24h】

Susceptibility Loci Associations with Prostate Cancer Risk in Northern Chinese Men

机译:北方北方男子患者患有前列腺癌风险的易感性锁骨

获取原文
           

摘要

Background: KLK3 gene products, like human prostate-specific antigen (PSA), are important biomarkers in the clinical diagnosis of prostate cancer (PCa). G protein-coupled receptor RFX6, C2orf43 and FOXP4 signaling plays important roles in the development of PCa. However, associations of these genes with PCa in northern Chinese men remain to be detailed. This study aimed to investigate their impact on occurrence and level of malignancy. Methods: All subjects were from Beijing and Tianjin, including 266 cases with prostate cancer and 288 normal individuals as controls. We evaluated associations between clinical covariates (age at diagnosis, prostate specific antigen, Gleason score, tumor stage and aggressive) and 6 candidate PCa risk loci, genotyped by PCR- high resolution melting curve and sequencing methods. Results: Case-control analysis of allelic frequency of PCa associated with PCa showed that one of the 6 candidate risk loci, rs339331 in the RFX6 gene, was associated with reduced risk of prostate cancer (odds ratio (OR) = 0.73, 95% confidence interval (CI) =0.57-0.94, P = 0.013) in northern Chinese men. In addition, subjects with CX (CC+TC) genotypes had a decreased risk for prostrate cancer compared to those carrying the TT homozygote (OR =0.64, 95% CI = 0.45- 0.90, P = 0.008). The TT genotype of 13q22 (rs9600079, T) was associated with tumor stage (P=0.044, OR=2.34, 95% CI=0.94-5.87). Other SNPs were not significantly associated with clinical covariates in prostate cancer (P 0.05). Conclusions. rs339331 in the RFX6 gene may be associated with prostate cancer as a susceptibility locus in northern Chinese men.
机译:背景:KLK3基因产物,如人类前列腺特异性抗原(PSA),是在临床诊断的前列腺癌(PCA)的重要生物标记。 G蛋白偶联受体RFX6,C2orf43和FOXP4信号传导在前列腺癌的发展起重要作用。然而,这些基因与前列腺癌在中国北方男人的协会仍有待详细说明。本研究旨在探讨其对发生和恶性程度的影响。方法:所有受试者都是来自北京和天津,其中包括266案件前列腺癌患者和288名正常人作对照。我们评估临床协变量之间的关联(诊断时的年龄,前列腺特异性抗原,Gleason评分,肿瘤分期和侵略性)和6候选前列腺癌风险基因座,通过PCR-高分辨率熔解曲线和测序方法进行基因分型。结果:与前列腺癌相关的前列腺癌的等位基因频率的病例 - 对照分析表明6候选风险基因座中的RFX6基因之一,rs339331,用前列腺癌的风险降低(比值比(OR)= 0.73,95%置信相关联间隔中国北方男性(CI)= 0.57-0.94,P = 0.013)。此外,CX(CC + TC)基因型受试者相比,那些携带TT纯合子用于前列腺癌风险降低(OR = 0.64,95%CI = 0.45 0.90,P = 0.008)。的13q22 TT基因型(rs9600079,T)与肿瘤阶段(P = 0.044,OR = 2.34,95%CI = 0.94-5.87)相关联。其它的SNP没有显著与前列腺癌(P> 0.05)的临床共变量相关联。结论。在RFX6基因rs339331可以与前列腺癌在中国北方男性易感基因有关。
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号